
HCA Healthcare (HCA) Stock Forecast & Price Target
HCA Healthcare (HCA) Analyst Ratings
Bulls say
HCA Healthcare is the largest provider of acute-care hospitals in the United States, with a wide network of facilities and strong financial flexibility. Despite transient challenges, such as the impact of flu and weather on Q1:26 results, HCA remains on track to meet its 2026 targets thanks to expected growth from newly approved state-directed payment programs and the ongoing outpatient expansion. With strong cash flow and a robust pipeline for future investments, the company has a promising outlook for long-term growth and profitability, supporting an upbeat outlook.
Bears say
HCA Healthcare is facing several headwinds that are negatively impacting its financial performance. The company has experienced a decline in admissions and emergency room visits due to the flu and weather in the first quarter, leading to a $180 million impact on EBITDA. The company also faced a $150 million headwind from HIX, with a 15% decline in Exchange admissions. The company's labor costs, professional fees, and supplies are also expected to be higher in the future, potentially leading to a contraction in its valuation multiple. Overall, these factors could result in lower than expected financial performance and may lead to a decrease in the stock price.
This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.
HCA Healthcare (HCA) Analyst Forecast & Price Prediction
Start investing in HCA Healthcare (HCA)
Order type
Buy in
Order amount
Est. shares
0 shares